IVIG
IVIG is a pharmaceutical drug with 47 clinical trials. Currently 8 active trials ongoing. Historical success rate of 80.8%.
Success Metrics
Based on 21 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
13
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
67.7%
21 of 31 finished
32.3%
10 ended early
8
trials recruiting
47
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Clinical Trials (47)
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura
Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC
IVIG (Gamunex-C) Treatment Study for POTS Subjects
Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy
The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics
Role of Immunoglobulin in Male Infertility
Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG
Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections
Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS
KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
IVIg to Treat BK Viremia in Kidney Transplant Recipients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 47